Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 500
Summary
- Conditions
- Breast Cancer
- Metastatic Prostate Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Health Services Research
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
This prospective, randomized controlled trial will evaluate the effect of two pre-test education methods on the level of participation in genetic testing for hereditary cancer risk. A prospective study examines outcomes before the development of a disease. The research study procedures include scree...
This prospective, randomized controlled trial will evaluate the effect of two pre-test education methods on the level of participation in genetic testing for hereditary cancer risk. A prospective study examines outcomes before the development of a disease. The research study procedures include screening for eligibility, randomization and a series of questionnaires. Participants will be randomized, or assigned by chance, to one of two methods of pre-genetic test education and after completing either pre-test education participants will be offered the opportunity to have genetic testing performed Two methods of pre-genetic test education: video education in-person counseling Genetic testing will be performed by blood draw. It is expected that 500 people will participate in this study Participants will be in the research study for up to 5 yrs after enrollment
Tracking Information
- NCT #
- NCT04330716
- Collaborators
- Ambry Genetics
- Investigators
- Principal Investigator: Huma Rana, MD Dana-Farber Cancer Institute
Get Well Soon